Ali­gos’ tri­al for oral MASH treat­ment suc­ceeds, but place­bo group shows odd trend

Ali­gos Ther­a­peu­tics’ oral treat­ment for an ad­vanced form of fat­ty liv­er dis­ease re­port­ed pos­i­tive re­sults in a Phase 2 tri­al, show­ing it was ef­fec­tive at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER